Search Results - V. E. Askarov

Combination BRAF/MEK Inhibitor Targeted Therapy and Immunotherapy (atezolizumab + vemurafenib + cobimetinib) for Metastatic Cutaneous Melanoma: Clinical Case by V. E. Askarov, A. V. Sultanbaev, K. V. Menshikov, V. S. Chalov, N. I. Sultanbaeva, I. A. Menshikova

Get full text

Eribulin in Metastatic Breast Cancer: Actual Clinical Practice by A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, I. A. Menshikova, N. I. Sultanbaeva, E. V. Popova, V. E. Askarov

Get full text

Combined Use of Cabozantinib and Nivolumab in Clinical Practice by V. E. Askarov, A. V. Sultanbaev, K. V. Menshikov, Sh. I. Musin, N. I. Sultanbaeva, E. V. Popova, I. A. Menshikova

Get full text